Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : NaF PLASMA
Age : 53 Year(s) Ref Doctor : SID : 3714986
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 13:25

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌▐█▐ █ █▐▌▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐▌▐█▐
█▌▌▐▌▐▌▐█▐
█
█
█▐▌▐▌
█▐▌▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:24
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌▐█▐ █ █▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌▐█▐ █ █▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌▐█▐ █ █▐▌▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

Plasma Glucose - Fasting 166 mg/dL Normal : 74 - 106

(Method: Hexokinase)
Impaired GT : 107 - 125
Diabetic : >or=126

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 1 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : SERUM

Age : 53 Year(s) Ref Doctor : SID : 3714988
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 16:24

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐█▐
█▌▌▐▌▐█▐
█
█
▌█▌▐▌▐▌
▌█▌▐▌▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:26
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

Calcium 9.8 mg/dL 8.8 - 10.6

(Method: Spectrophotometry(Cresol Complex))

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 2 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : SERUM

Age : 53 Year(s) Ref Doctor : SID : 3714988
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 16:24

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐█▐
█▌▌▐▌▐█▐
█
█
▌█▌▐▌▐▌
▌█▌▐▌▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:26
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

LIPID PROFILE
Cholesterol - Total 194 mg/dL < 200 : Desirable
(Method: CHOD/PAP)
200-239 : Borderline risk
> 240 : High risk
Cholesterol - HDL 42 mg/dL < 40 : Low
(Method: Direct)
40 - 60 : Optimal
> 60 : Desirable
Cholesterol - LDL (Direct) 121 mg/dL < 100 : Normal
(Method: Homogeneous enzymatic end point assay)
100 - 129 : Desirable
130 – 159 : Borderline-High
160 – 189 : High
> 190 : Very High
Cholesterol VLDL 30.8 mg/dL 7 - 40
(Method: Calculation)

Triglycerides 154 mg/dL < 150 : Normal

(Method: Lipase / Glycerol Kinase)
150–199 : Borderline-High
200–499 : High
> 500 : Very High
Total cholesterol/HDL ratio 4.6 Ratio 0 - 5.0
(Method: Calculation)

LDL / HDL Ratio 2.9 Ratio 0 - 3.5

(Method: Calculation)

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 3 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : SERUM

Age : 53 Year(s) Ref Doctor : SID : 3714988
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 16:24

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐█▐
█▌▌▐▌▐█▐
█
█
▌█▌▐▌▐▌
▌█▌▐▌▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:26
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

IRON PROFILE
Iron 76.9 µg/dL 60 - 180
(Method: Ferene)

Iron Binding Capacity - Total (TIBC) 301 µg/dL 240 - 450

(Method: Ferrozine)

Transferrin 204.8 µg/dL 176 - 280

(Method: Immunoturbidometry)

Transferrin % 25.5 % 20 - 50
(Method: Calculation)

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 4 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : SERUM

Age : 53 Year(s) Ref Doctor : SID : 3714988
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 16:24

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐█▐
█▌▌▐▌▐█▐
█
█
▌█▌▐▌▐▌
▌█▌▐▌▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:26
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

KIDNEY BASIC SCREEN

Creatinine(Serum) 0.7 mg/dL 0.51 - 1.0
(Method: JAFFE-Kinetic)

Urea (Serum) 18.9 mg/dL 17 - 43

(Method: UV-Kinetic)

Blood Urea Nitrogen (BUN)/Creatinine 12.6 ratio 6 - 22

(Method: Calculation)

Sodium(Serum) 141 mmol/L 135 - 150

(Method: ISE Direct)

Potassium(Serum) 4.6 mmol/L 3.5 - 5.0

(Method: ISE Direct)

Chloride(Serum) 102 mmol/L 94 - 110

(Method: ISE Direct)

Uric Acid 4.5 mg/dL 2.6 - 6.0

(Method: Uricase)

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 5 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : SERUM

Age : 53 Year(s) Ref Doctor : SID : 3714988
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 16:24

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐█▐
█▌▌▐▌▐█▐
█
█
▌█▌▐▌▐▌
▌█▌▐▌▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:26
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

LIVER FUNCTION PROFILE

Bilirubin Total 0.5 mg/dL 0.3 - 1.2
(Method: Diazotised Sulphanilic Acid)

Bilirubin Direct 0.1 mg/dL < 0.2

(Method: Diazotised Sulphanilic Acid)

Bilirubin Indirect 0.4 mg/dL 0 - 1.0

(Method: Calculation)

Alkaline Phosphatase (ALP) 135 U/L 30 - 120

(Method: AMP Buffer)

Alanine Transaminase (ALT) 24 U/L < 35

(Method: UV with pyridoxal - 5 - phosphate)

Aspartate Aminotransferase(AST) 15 U/L < 35

(Method: UV with Pyridoxal-5-phosphate)

Y- Glutamyl Transferase (GGT) 30 U/L < 38

(Method: g-Glut-3-carboxy-4 nitro)

Protein Total 7.2 g/dL 6.6 - 8.3

(Method: BIURET)

Albumin 4.2 g/dL 3.5 - 5.2

(Method: Bromocresol Purple)

Globulin 3 g/dL 2.5 - 3.5

(Method: Calculated)

Albumin / Globulin Ratio 1.4 ratio 1.0 - 2.1

(Method: Calculation)

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 6 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : SERUM

Age : 53 Year(s) Ref Doctor : SID : 3714988
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 16:24

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐█▐
█▌▌▐▌▐█▐
█
█
▌█▌▐▌▐▌
▌█▌▐▌▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:26
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐█▐ █ ▌█▌▐▌▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

THYROID PANEL I
TriIodothyronine Total (TT3) 114.30 ng/dL 126 – 258 : 1 Yr – 5 Yr
(Method: Chemiluminescence)
96 – 227 : 6 Yr – 15 Yr
91 – 164 : 16 Yr – 18 Yr
87 – 178 : > 18 years
Pregnancy :
1st Trimester : 81 - 190
2nd & 3rd Trimester:100 - 260
Thyroxine - Total (TT4) 8.99 µg/dL 6.09 - 12.23
(Method: Chemiluminescence)
Pregnancy:
4.6-16.5 : 1st Trimester
4.6-18.5 : 2nd & 3rd Tri
Thyroid Stimulating Hormone (TSH) 5.67 µIU/mL 0.46 - 8.10 : 1 yrs-5 Years
(Method: Ultra-sensitive chemiluminescence)
0.36 - 5.80 : 6 yrs-18 Years
0.38 - 5.33 : 18 yrs-88 Years
0.50 - 8.90 : >88 Years
Pregnancy ranges:
1st Trimester:0.05 - 3.70
2nd Trimester:0.31 - 4.35
3rd Trimister:0.41 - 5.18.

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 7 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : WB EDTA

Age : 53 Year(s) Ref Doctor : SID : 3714985
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 13:25

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐▌█▌▐
█▌▌▐▌▐▌█▌▐
██▐▐
██▐▐
▐▌
▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:24
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

GLYCOSYLATED HEMOGLOBIN ( HbA1c )

(Method: ion-exchange high-performance liquid chromatography(HPLC))

Hemoglobin A1c (HbA1c) 7.3 % < 6 : Non Diabetic

6-7 : Good Control
7-8 : Poor Control
> 8 : Alert
Estimated average glucose (eAG) 162.81 HbA1c(%) : eAG(mg/dL)
6 : 125
6.5 : 140
7 : 154
7.5 : 169
8 : 183
8.5 : 197
9 : 212
9.5 : 226
10 : 240

Ch.Samuel Dr. MADHUMATI.B

Manager Technical LAB DIRECTOR

Page 8 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : WB EDTA

Age : 53 Year(s) Ref Doctor : SID : 3714985
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 13:25

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐▌█▌▐
█▌▌▐▌▐▌█▌▐
██▐▐
██▐▐
▐▌
▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:24
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█

HAEMATOLOGY
Test Description Result Units Biological Reference Ranges

Erythrocyte Sedimentation Rate (ESR) 10 mm/Hour <19

(Method: Westergren's method)

Ch.Vinay Kumar Dr. MADHUMATI.B

Group Leader LAB DIRECTOR

Page 9 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
 Medical Laboratory Report

SYEDA NOOR AYESHA APL Code :APL-KA-166 Sample Type : WB EDTA

Age : 53 Year(s) Ref Doctor : SID : 3714985
Gender : Female Ref Cust : Collected on : 2022-12-20 00:00

Regd on : 2022-12-20 13:25

█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐
█▐
▌▐▌▐▐█
▌▐▌▐▐█
█▌█▐█▐
█▌█▐█▐
█▌▐▌█
█▌▐▌█
▌▐█▐█
▌▐█▐█
▌█
▌█
█▌▌▐▌▐▌█▌▐
█▌▌▐▌▐▌█▌▐
██▐▐
██▐▐
▐▌
▐▌
█▌▌█
█▌▌█ Reported on : 2022-12-20 16:24
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█
█▐ ▌▐▌▐▐█ █▌█▐█▐ █▌▐▌█ ▌▐█▐█ ▌█ █▌▌▐▌▐▌█▌▐ ██▐▐ ▐▌ █▌▌█

HAEMATOLOGY
Test Description Result Units Biological Reference Ranges

COMPLETE BLOOD PICTURE

Hemoglobin 14.6 g/dL 11.5 - 16.0
(Method: Spectrophotometry)

Erythrocyte Count (RBC Count) 4.7 mil/µL 3.8 - 4.8

(Method: Impedance)

Packed Cell Volume(Hematocrit) 42.9 % 40 - 47

(Method: Calculated)

Platelet Count 3.54 lakh/Cumm 1.50 - 4.50

(Method: Impedance/ Microscopy)

Red Cell Indices

(Method: Automated 5 part Cell counter/ Calculated)

MCV 91 fl 83 - 101
MCH 31.2 pg 27 - 32
MCHC 34.1 g/dL 31.5 - 34.5
RDW-CV 13.3 % 11.5 - 14.5
Total Count and Differential Count
(Method: Impedance/Microscopy)

Total Leucocyte Count(WBC) 9100 cells/Cumm 4000 - 11000

Neutrophils 60 % 40 - 75
Lymphocytes 33 % 20 - 40
Eosinophils 02 % 0-6
Monocytes 05 % 2 - 10
Basophils 00 % 0-1
Microscopic Blood Picture
(Method: Microscopy)

RBC Morphology Normocytic Normochromic Cells

WBC Morphology Normal in Morphology
Platelet Morphology Adequate
Hemoparasites Not found
Impression Normal Study
Advise Correlate Clinically

Ch.Vinay Kumar Dr. MADHUMATI.B

Group Leader LAB DIRECTOR

Page 10 of 10

This is an electronically authenticated report. Report Printed Date : 20/12/2022 19:14 Report #
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.